Caeli Vascular

Caeli Vascular is an early-stage medical device company dedicated to developing next-generation treatments for venous thromboembolism (VTE). The company's primary focus is on a novel mechanical thrombectomy system designed to improve the removal of large-volume blood clots in patients with deep vein thrombosis and pulmonary embolism. By utilizing a unique mechanism of action that aims to minimize blood loss while maximizing clot extraction efficiency, Caeli Vascular seeks to address the limitations of current interventional therapies. The company is currently advancing its technology through pre-clinical development and early engineering phases to prepare for clinical evaluation.